This document provides evidencebased clinical practice guidelines on the management of adult patients with communityacquired pneumonia. Descriptive study of an institutional record during 2007 to 2012. Prospective comparison of severity scores for predicting mortality in communityacquired pneumonia 73 rev esp quimioter 2012. Communityacquired pneumonia cap is one of the main causes of mortality in children aged less than 5 years, responsible for 19% of all deaths worldwide. Diagnosis and treatment of adults with communityacquired. A proposal for the management of communityacquired.
Impact of bacteremia in a cohort of patients with pneumococcal pneumonia j bras pneumol. Communityacquired pneumonia is one of the leading causes of morbidity and mortality in mexico and the world. Introduccion, objetivos y metodologia introduccion. Seventy four patients were included and followedup on. Managementbased risk prediction in communityacquired pneumonia by scores and biomarkers. We use cookies to offer you a better experience, personalize content, tailor advertising, provide social media features, and better understand the use of our services. The communityacquired pneumonia cap, is defined as pneumonia. A clinical questionnaire was submitted to 36 physicians from latin america. Cytokine activation patterns and biomarkers are influenced by microorganisms in communityacquired pneumonia. Prospective comparison of severity scores for predicting. New guidelines of the spanish society of chest diseases and thoracic surgery separ. Infectious diseases society of americaamerican thoracic society consensus guidelines on the management of communityacquired pneumonia in adults. Community acquired pneumonia cap is a common childhood disease, involving several paediatric subspecialties in its diagnosis and treatment.
1529 317 540 604 379 1431 876 1472 154 500 662 254 759 1181 1184 766 1378 718 1316 1548 1015 1012 851 800 1323 1037 1306 952 407 121 142 150